BioNTech SE (BNTX)
286.47
+17.05 +6.33%
NASDAQ
Oct 21, 16:00
286.00
-0.47 -0.16%
After-Hours: 19:59
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 9.357B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 19.11 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 4.910B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 83.35% |
| Profit Margin (Quarterly) | 52.50% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 69.47B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 8.035 |
| PE Ratio | 14.99 |
| Price to Book Value | 10.65 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.0468 |
| Free Cash Flow (Quarterly) | -157.21M |
| Return on Equity | Upgrade |
View All BNTX News
News
-
WireHeadlineTime (ET)
-
SA Breaking News10/21 17:50
-
Yahoo10/21 16:08
-
Yahoo10/21 15:50
-
SA Breaking News10/21 13:40
-
Yahoo10/21 12:55
-
MT Newswires10/21 12:47
-
Yahoo10/21 11:27
-
MT Newswires10/21 11:06
-
Yahoo10/21 09:44
-
Yahoo10/21 09:30
-
Yahoo10/21 08:45
-
MT Newswires10/21 08:20
-
Yahoo10/21 07:21
-
Yahoo10/21 07:02
-
Yahoo10/21 06:57
-
Yahoo10/21 06:45
-
Globe Newswire10/21 06:45
-
MT Newswires10/21 04:55
-
Yahoo10/21 04:16
-
Yahoo10/20 19:32
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/10/2021 | Earnings Results | Q3 2021 Earnings Results |
| 11/10/2021 | Earnings Calls | Q3 2021 Earnings Call |
| 08/09/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/09/2021 08:00 EST | Earnings Calls | Q2 2021 Earnings Call |
| 06/22/2021 08:00 EST | AGM | 2020 Annual General Meeting |
| 05/10/2021 | Earnings Results | Q1 2021 Earnings Results |
| 05/10/2021 08:00 EST | Earnings Calls | Q1 2021 Earnings Call |
| 03/30/2021 | Earnings Results | Q4 2020 Earnings Results |
| 03/30/2021 08:00 EST | Earnings Calls | Q4 2020 Earnings Call |
| 11/10/2020 | Earnings Results | Q3 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
- URL: https://www.biontech.de
- Investor Relations URL: https://investors.biontech.de/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: N/A
- Next Earnings Release: Nov. 10, 2021
- Last Earnings Release: Aug. 09, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 286.47 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| IDNA | iShares Genomics Immnlgy & Hlthcr ETF | 4.30% |
| BBH | VanEck Biotech ETF | 3.88% |
| FBT | First Trust NYSE Arca Biotech ETF | 3.65% |
| IBB | iShares Biotechnology ETF | 3.54% |
| POAGX | PRIMECAP Odyssey Aggressive Growth | 3.28% |
| PJHRX | PGIM Jennison Health Sciences R | 2.80% |
| FPXI | First Trust International Eq Opps ETF | 2.31% |
| VHCOX | Vanguard Capital Opportunity Inv | 2.30% |
| IPO | Renaissance IPO ETF | 1.91% |
| PRJDX | PGIM Jennison Global Opportunities R4 | 1.75% |
| PWJBX | PGIM Jennison International Opps R2 | 1.73% |
| PRHSX | T. Rowe Price Health Sciences | 1.26% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BNTX Tweets Stocktwits
Advertisement
